60 reports

  • 2.3 Antifungal Drugs
  • 2.2 Antifungal Agents Overview

Scope of the Report The report titled “Global Antifungal Market With Focus on Invasive Fungal Infections: 2016-2020” provides an in-depth analysis of the global antifungal market with detailed analysis of market size on the basis of value along with the comprehensive examination of each of the segments of the market, namely,...

  • Antifungal
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SCYNEXIS, Inc.

Global Antifungal Drugs Market Forecast 2017-2025 ##.

  • Antifungal
  • OTC
  • World

Previously, BCC Research examined the antifungal market in its 2003 report, PHM##A The Market for Antifungal Drugs, in PHM##B Global Markets for Antifungal Agents in PHM##C Antifungal Drugs: Technologies and Global Markets and in the 2014 report PHM##E

  • Antifungal
  • OTC
  • APAC
  • World
  • Market Segment

Global AntiFungal Agents Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023 ##.

  • Antifungal
  • OTC
  • World
  • Forecast

Global Antifungal Agents Market Forecast 2017-2025 ##.

  • Antifungal
  • OTC
  • World
  • Antifungal drug resistance
  • Increased funding for antifungal research

About Antifungal Drugs Antifungal drugs are chemical compounds used to kill or inhibit the growth of fungi. These drugs act by various mechanisms such as the inhibition of cell division, the inhibition of cell wall formation, and cell membrane disruption. Technavio’s analysts forecast the global antifungal drugs market...

  • Antifungal
  • Astellas Pharma Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.

The 2019-2024 World Outlook for at-Home Vaginal Antifungal Treatments ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Antifungal
  • OTC
  • World
  • Demand

Inc. ##. ## Pfizer Inc. ##. ## Enzon Pharmaceuticals ##. ## PerkinElmer, Inc., ##. ## Alternaria ##. ## Sigma-Aldrich ##. ## Astellas Pharma Inc List of Tables Table ## Global Antifungal Drugs Market Outlook, By Region (2014-2022) ($MN) Table ## Global Antifungal Drugs Market Outl

  • Antifungal
  • APAC
  • North America
  • World
  • Market Size

GSK: OPERATING SEGMENTS List of Figures FIGURE ##.

  • Antifungal
  • OTC
  • World
  • Forecast

## Global Antifungal Drugs Market By Region, Market Forecast (2013-2025) (US $MN) Table ## Global Antifungal Drugs Market By Drug Type, Market Forecast (2013-2025) (US $MN) Table ## Global Antifungal Drugs Market By Polyenes, Market Forecast (2013-2025) (US $MN) Tabl

  • Antifungal
  • OTC
  • United States
  • World
  • Forecast

Asia-Pacific Antifungal Drugs Market Forecast 2017-2025 ##.

  • Antifungal
  • OTC
  • APAC
  • Forecast
  • 7: Prescription Antifungal Drugs
  • PRESCRIPTION ANTIFUNGAL FORMULATIONS IN DEVELOPMENT

World Prescription Dermatological Drugs Market details the various categories of prescription dermatological drugs, describes the worldwide market for prescription dermatological drugs, and identifies major market factors that may help to shape the worldwide market for prescription dermatological drugs in the future.

  • Antifungal
  • World
  • Market Size
  • Galderma S.A.
  • Valeant Pharmaceuticals International, Inc.

## North America antifungal drugs market, by drug class, 2014 - 2025 (USD Million) TABLE ## North America antifungal drugs market, by Indications, 2014 - 2025 (USD Million) TABLE ## U. S. antifungal drugs market, by drug class, 2014 - 2025 (USD Million) TABLE ## U. S.

  • Antifungal
  • OTC
  • United States
  • Increased funding for antifungal research
  • Increased funding for antifungal research

About Tinea Pedis Treatment Tinea pedis, also known as athlete’s foot, is caused by dermatophyte fungus on foot and can spread to toenails and hands. It is a dermatophyte infection of the soles of the feet and the interdigital spaces. Tinea pedis thrives in warm, humid conditions and is most common among young adult men. Tinea...

  • Antifungal
  • Infectious Disease
  • World
  • Valeant Pharmaceuticals International, Inc.
  • Viamet Pharmaceuticals, Inc.

Antifungals ##. ##. ##.

  • Antifungal
  • Infectious Disease
  • Latin America
  • North America
  • Market Size
  • OTHER ANTIFUNGAL AGENTS
  • Prescription Antifungal Drugs

The worldwide market for prescription dermatological drugs encompasses a wide variety of products that treat disorders of the skin as well as the effects of aging. It’s a very dynamic time for the prescription dermatological drug industry. Consolidation, economic times, new technologies and genetic discoveries are among the trends that the...

  • Antifungal
  • Allergan plc
  • Galderma S.A.
  • Pfizer Inc.
  • Valeant Pharmaceuticals International, Inc.

Europe Anti Fungal Market Forecast 2017-2025 ##.

  • Antifungal
  • OTC
  • Europe

Asia-Pacific Anti Fungal Market Forecast 2017-2025 ##.

  • Antifungal
  • OTC
  • APAC
  • Galderma
  • Market segmentation by route of administration

About Dermatophytic Onychomycosis Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes,...

  • Antifungal
  • Anacor Pharmaceuticals, Inc.
  • Janssen Biotech, Inc.
  • Novartis AG
  • Valeant Pharmaceuticals International, Inc.
  • Ketoconazole
  • Amphotericin B Sales Volume and Market Share

This study focuses on China’s Anti Dermatomycosis Skin Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Antifungal
  • China
  • Demand
  • Trade
  • Xian-Janssen Pharmaceutical Ltd.
  • Chapter IV
  • Amphotericin B Sales Volume and Market Share

China’s demand for Anti Dermatomycosis Skin Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export,...

  • Antifungal
  • China
  • Demand
  • Market Size
  • Xian-Janssen Pharmaceutical Ltd.
  • TECHNOLOGY & SYSTEMS
  • SIMILAR INDUSTRIES

Athlete's Foot Treatment Manufacturing OTC The Athlete's Foot Treatment Manufacturing OTC industry provides highly inelastic products that have no direct substitutes in the market and therefore benefits from a steady stream of revenue, despite the high internal and external competition it experiences. Over the next five years,...

  • Antifungal
  • United States
  • Bayer AG
  • GlaxoSmithKline plc
  • Novartis AG
  • Five: Anti-infectives
  • OVERVIEW

Over the past 38 years the U.S. Rx-to-OTC market has grown into a $7.8 billion market. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide...

  • Antifungal
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Jan 11, 2018: Novan to Present Positive Phase 2 Results for SB208 Antifungal Program at Winter Clinical Dermatology Conference
  • Mar 12, 2014: Viamet Reports Positive Interim Results of Phase 2 Interdigital Tinea Pedis Study of VT-1161

Tinea pedis (Athlete Foot) - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Tinea pedis (Athlete Foot) - Pipeline Review, H1 2018, provides an overview of the Tinea pedis (Athlete Foot) (Infectious Disease) pipeline landscape. Athlete’s...

  • Antifungal
  • United States
  • World
  • Product Initiative
  • Novan, Inc.
  • antifungal peptide platform technology. This latest grant broadens the commercial applicability of NovaBiotics novel antifungal peptide technology.
  • Mechanism Of Action R&D Progress

Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2018, provides an overview of the Onychomycosis (Tinea Unguium) (Infectious Disease) pipeline landscape. Onychomycosis...

  • Antifungal
  • Infectious Disease
  • United States
  • Product Initiative
  • Viamet Pharmaceuticals, Inc.
  • Oct 05, 2017: Researchers help develop new antifungal drug
  • Sep 27, 2017: SCYNEXIS to Present Data on Lead Antifungal Candidate SCY-078 at IDWeek 2017

Aspergillosis - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Aspergillosis - Pipeline Review, H2 2017, provides an overview of the Aspergillosis (Infectious Disease) pipeline landscape. Aspergillosis is an infection or...

  • Antifungal
  • United States
  • Company
  • Product Initiative
  • SCYNEXIS, Inc.
  • APR 24, 2015: VIAMET TO PROVIDE UPDATE ON VT-1129, NOVEL ANTIFUNGAL PROGRAM AT ECCMID 2015
  • FEATURED NEWS & PRESS RELEASES

Meningitis - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Meningitis - Pipeline Review, H1 2018, provides an overview of the Meningitis (Infectious Disease) pipeline landscape. "Meningitis is the inflammation caused by...

  • Antifungal
  • Infectious Disease
  • Meningococcal
  • United States
  • Product Initiative
  • Sep 27, 2017: SCYNEXIS to Present Data on Lead Antifungal Candidate SCY-078 at IDWeek 2017
  • Apr 12, 2017: SCYNEXIS to Present SCY-078 Data on Novel Lead Anti-infective Candidate at 27th European Congress of Clinical Microbiology and Infectious Diseases

Summary Scynexis Inc (Scynexis) is a pharmaceutical company that discovers, develops and commercializes novel anti-infective for various therapeutic needs.The company’s pipeline products comprise SCY-078, is used for invasive fungal infections; SCY-635, is used for the treatment of Hepatitis C (HCV); SCYX-7158, is used...

  • Antifungal
  • Therapy
  • United States
  • Company
  • SCYNEXIS, Inc.
  • NOVABIOTICS NOVEL ANTIFUNGAL PEPTIDE TECHNOLOGY.
  • HXP-124 - DRUG PROFILE

Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2017, provides an overview of the Onychomycosis (Tinea Unguium) (Infectious Disease) pipeline landscape. Onychomycosis...

  • Antifungal
  • Pharmaceutical
  • United States
  • Product Initiative
  • Viamet Pharmaceuticals, Inc.
  • ANTIFUNGAL PORTFOLIO.
  • Mar 07, 2016: Vical Initiates Phase 1 Trial of Novel Antifungal Compound VL-2397

Aspergillosis - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Aspergillosis - Pipeline Review, H1 2018, provides an overview of the Aspergillosis (Infectious Disease) pipeline landscape. Aspergillosis is an infection or...

  • Antifungal
  • Infectious Disease
  • United States
  • World
  • Product Initiative